Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man-Reference-Cited by-同舟云学术

Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man

Published:2003-05 Issue:2 Volume:46 Page:139-163
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Slavin Shimon,Morecki Shoshana,Weiss Lola,Or Reuven

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference126 articles.

1. Marrow transplantation for malignant diseases;Thomas;J. Clin. Oncol.,1983

2. Chronic leukemia;Gratwohl;Lancet,1998

3. Report from the international bone marrow transplant registry and autologous blood and marrow transplant registry—North America. Clinical transplants, 1995;Passweg,1996

4. Principles of cancer biology: tumour immunology;Bast,1985

5. Effective graft vs leukemia effects independent of graft vs host disease after T-Cell depleted allogeneic bone marrow transplantation in a murine model of B Cell leukemia/lymphoma. Role of cell therapy and rIL-2;Weiss;J. Immunol.,1994

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?;Tumor Biology;2017-06

2. Submyeloablative conditioning with busulfan permits bone marrow-derived cell accumulation in a murine model of Alzheimer’s disease;Neuroscience Letters;2015-02

3. Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity;Pharmacological Research;2014-01

4. Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial;Journal of Translational Medicine;2013-07-02

5. Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators;Biology of Blood and Marrow Transplantation;2009-04